Efficacy and tolerability of tapentadol extended release (ER) in patients with chronic, painful diabetic peripheral neuropathy (DPN): results of a phase 3, randomized-withdrawal, placebo-controlled study
A. Vinik, D. Shapiro, C. Rauschkolb-Löffler, B. Lange, K. Karcher, D. Pennett, M. EtropolskiVolume:
13
Year:
2012
Language:
english
DOI:
10.1016/j.jpain.2012.01.301
File:
PDF, 38 KB
english, 2012